Shares of insurers and pharmacy benefit manager (PBM) companies such as Centene, Elevance Health, Humana and CVS Health are ...

Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

CVS Health's poor 2024 performance could be turning around in 2025 with a new CEO and potential rebound, despite challenges.

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...

Former Rep. Larry Bucshon (R-Ind.) said in an interview Thursday that he expects pieces of health care legislation that were ...

UnitedHealthcare's legal drug dealing arm is, according to the government, massively marking up the cost of life-saving ...

UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector ...

UnitedHealth Group has reported quarterly profits of $5.5 billion after tax in its first earnings release since the killing ...

UnitedHealth posted a better-than-expected fourth-quarter profit, but a nagging rise in medical costs and care utilization ...

Despite the shocking incident, and subsequent financial loss, the company posted a better-than-expected profit in the final ...

A U.S. appeals court temporarily blocked a generic version of Novartis' Entresto, and new price limits challenge pharma as ...